Access Pharmaceuticals Income Statement
View: Annual | Quarterly
This data is provided as per license from EDGAR Online
| Quarter Ending Mar 08* |
Quarter Ending Sep 07 |
Quarter Ending Jun 07 |
Quarter Ending Mar 07 |
Quarter Ending Dec 06 |
|
|---|---|---|---|---|---|
| Revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Cost of Goods Sold | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| Gross Profit Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| SG&A Expense | 10.5 | 1.6 | 1.5 | (0.7) | (1.6) |
| Depreciation & Amortization | 0.1 | 0.1 | 0.2 | 2.3 | 2.6 |
| Operating Income | (10.6) | (1.6) | (1.7) | (1.6) | (1.0) |
| Operating Margin | -- | -- | -- | -- | -- |
| Nonoperating Income | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 |
| Nonoperating Expenses | 0.1 | 0.3 | 0.4 | 2.5 | 2.2 |
| Income Before Taxes | (10.6) | (2.0) | (2.1) | (4.1) | (3.2) |
| Income Taxes | -- | -- | -- | -- | (0.2) |
| Net Income After Taxes | (10.6) | (2.0) | (2.1) | (4.1) | (3.1) |
| Continuing Operations | (10.6) | (2.0) | (2.1) | (4.1) | (3.0) |
| Discontinued Operations | -- | -- | -- | -- | 0.4 |
| Total Operations | (10.6) | (2.0) | (2.1) | (4.1) | (2.7) |
| Total Net Income | (10.6) | (2.0) | (2.1) | (4.1) | (2.7) |
| Net Profit Margin | -- | -- | -- | -- | -- |
| Diluted EPS from Total Net Income ($) | (2.31) | (0.55) | (0.59) | (1.17) | (0.76) |
| Dividends per Share | -- | -- | -- | -- | -- |
This data is provided as per license from EDGAR Online
